Literature DB >> 10225302

Surgical management of advanced and recurrent cervical cancer.

R Estape1, R Angioli.   

Abstract

Since the early 1940s, the incidence of cervical cancer has dramatically decreased due in large part to the work of Papanicolaou and Traut. Successful treatment can now be done using simple or radical surgical intervention for early invasive lesions and radiation therapy for more advanced lesions. However, despite current advances in screening and early treatment, local recurrences still happen and are difficult to treat. The natural history of cervical cancers is that of a slowly growing, locally invasive tumor. As such, it lends itself to radical surgical resection in selected patients prior to distant metastasis. Current advances in intraoperative and postoperative monitoring, as well as improved surgical techniques and devices, have decreased the morbidity and mortality of radical surgical procedures to acceptable levels. Current data associated with these procedures for advanced or recurrent cervical cancer are described.

Entities:  

Mesh:

Year:  1999        PMID: 10225302     DOI: 10.1002/(sici)1098-2388(199904/05)16:3<236::aid-ssu8>3.0.co;2-j

Source DB:  PubMed          Journal:  Semin Surg Oncol        ISSN: 1098-2388


  9 in total

1.  Laparoscopic salvage total pelvic exenteration: Is it possible post-chemo-radiotherapy?

Authors:  H Patel; J V Joseph; A Amodeo; K Kothari
Journal:  J Minim Access Surg       Date:  2009-10       Impact factor: 1.407

Review 2.  Recurrent cervical cancer.

Authors:  Mario M Leitao; Dennis S Chi
Journal:  Curr Treat Options Oncol       Date:  2002-04

3.  Role of New Functional MRI Techniques in the Diagnosis, Staging, and Followup of Gynecological Cancer: Comparison with PET-CT.

Authors:  Elena Alvarez Moreno; Mar Jimenez de la Peña; Raquel Cano Alonso
Journal:  Radiol Res Pract       Date:  2012-01-18

4.  Pre-exenterative chemotherapy, a novel therapeutic approach for patients with persistent or recurrent cervical cancer.

Authors:  Carlos Lopez-Graniel; Rigoberto Dolores; Lucely Cetina; Aaron Gonzalez; David Cantu; Jose Chanona; Jesus Uribe; Myrna Candelaria; Rocio Brom; Jaime de la Garza; Alfonso Duenas-Gonzalez
Journal:  BMC Cancer       Date:  2005-09-19       Impact factor: 4.430

Review 5.  Total pelvic exenteration for pelvic recurrence after advanced epithelial ovarian cancer--A case report and literature review.

Authors:  N Bacalbașa; I Bălescu
Journal:  J Med Life       Date:  2015 Jul-Sep

6.  Cancer of the cervix uteri: 2021 update.

Authors:  Neerja Bhatla; Daisuke Aoki; Daya Nand Sharma; Rengaswamy Sankaranarayanan
Journal:  Int J Gynaecol Obstet       Date:  2021-10       Impact factor: 4.447

7.  SUCCOR Risk: Design and Validation of a Recurrence Prediction Index for Early-Stage Cervical Cancer.

Authors:  Nabil Manzour; Luis Chiva; Enrique Chacón; Nerea Martin-Calvo; Felix Boria; José A Minguez; Juan L Alcazar
Journal:  Ann Surg Oncol       Date:  2022-04-16       Impact factor: 4.339

8.  RapidArc for centrally recurrent cervical cancer in the vaginal cuff following primary surgical therapy: a case report.

Authors:  I Lalya; A Maghous; E Marnouche; N Zaghba; K Andaloussi; M Elmarjany; K Hadadi; H Sifat; H Mansouri
Journal:  World J Surg Oncol       Date:  2016-01-22       Impact factor: 2.754

9.  A novel arylbenzofuran induces cervical cancer cell apoptosis and G1/S arrest through ERK-mediated Cdk2/cyclin-A signaling pathway.

Authors:  Pinghong Ming; Ting Cai; Jin Li; Yong Ning; Shengao Xie; Tao Tao; Faqing Tang
Journal:  Oncotarget       Date:  2016-07-05
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.